Navigation Links
Patheon to Showcase Controlled Release Capabilities at CRS 2013

(PRWEB) July 15, 2013

Patheon Inc., a leading provider of contract development and manufacturing services to the global pharmaceutical industry, announced today that the company will showcase its controlled release capabilities and softgel technologies at the 40th Annual Meeting & Exposition of the Controlled Release Society (CRS) in Honolulu, Hawaii on July 21 – 24, 2013.

Controlled release technologies often present complex challenges in both development and manufacturing. The scientists at Patheon have years of experience in both of these fields and offer a variety of services and resources to move products from early development to market, while maintaining a longstanding commitment to quality and safety. Patheon offers controlled-release technologies in a multitude of dose forms, including tablets and softgels, to allow customers to cater to their target market and to expand the possible applications of a drug.

Two poster presentations will be given by Abhijit Gokhale, Ph.D., Senior Scientist, Formulation and Process Development, Patheon Inc., on Monday, July 22 and Tuesday, July 23. The presentations will cover extrusion spheronization technique for controlled release of pharmaceutical drugs and formulation development of poorly stable and poorly permeable drugs. Visit for more information.

Patheon representatives will also be available to meet at the CRS conference from July 21 – July 24, 2013 at booth #207, showcasing several of Patheon’s key service offerings. To schedule a meeting in advance send an email to events(at)patheon(dot)com.

Furthermore, Patheon has also recently been published in Drug Development & Delivery’s June 2013 issue; Controlled Release Innovations. Dr. Abhijit Gokhale and Prabal Sundararajan discuss orally disintegrating tablets in their article entitled “Novel Controlled Release Formulation for Orally Disintegrating Tablets Using Ion Exchange Resins.” This publication is just one of many among a library of thought leadership concerning controlled release technologies at Patheon. Visit our Knowledge Library to learn more.

About Patheon

Patheon Inc. (TSX: PTI) is a leading provider of contract development and commercial manufacturing services to the global pharmaceutical industry for a full array of solid and sterile dosage forms. Through the company’s recent acquisition of Banner Pharmacaps – a market leader in soft gelatin capsule technology – Patheon now also includes a proprietary products and technology business.

Patheon provides the highest quality products and services to approximately 300 of the world's leading pharmaceutical and biotechnology companies. The company's integrated network consists of 17 locations, including 13 commercial contract manufacturing facilities and 8 development centers across North America and Europe. Patheon enables customer products to be launched with confidence anywhere in the world. For more information visit

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Patheon-Sponsored Event to Highlight “Product Enhancement Through Complex Dosage Forms: Adding Value to Products’ Lifecycle Management”
2. Patheon to Host Complimentary Seminar on “Formulation, Funding and First-in-Man: A Stepwise Guide to Clinical Success”
3. Patheon to Host Webinar on “Accelerating the Drug Development Trajectory by Improving Solubility of New Compounds”
4. Patheon to Present on “Cleaning Validation: Science, Risk and Novel Approaches to Testing”
5. Patheon to Feature its Complex Formulation Technologies Expertise at the Upcoming CPhI – P-MEC –ICSE – BioPh – Pharmatec – Medtec Japan – Conference
6. Patheon to Showcase High Potency Capabilities at Upcoming Tradeshows
7. Patheon Exhibits and Presents at the 2013 IQPC Global Formulation and Drug Delivery Summit
8. Patheon to Present New Updates in Drug Formulation and Bioavailability
9. Patheon to Present at 2013 DCAT Week
10. Patheon Exhibits at the 2013 Biopharmaceutical Development and Production Week
11. Patheon to Present at Informex USA
Post Your Comments:
(Date:11/24/2015)... /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ:  AEZS) (TSX: AEZ) (the ... the Toronto Stock Exchange, confirms that as of the ... developments that would cause the recent movements in the ... --> About Aeterna Zentaris Inc. ... Aeterna Zentaris is a specialty biopharmaceutical company engaged in ...
(Date:11/24/2015)... LEXINGTON, Massachusetts , November 24, 2015 ... Officer, will participate in the Piper Jaffray 27 th Annual ... on Tuesday, December 1, 2015, at 8:30 a.m. EST (1:30 p.m. ... Poulton , Chief Financial Officer, will participate in the Piper Jaffray ... City , NY on Tuesday, December 1, 2015, at 8:30 ...
(Date:11/24/2015)... , ... November 24, 2015 , ... ... the environment are paramount. Insertion points for in-line sensors can represent a weak ... the InTrac 781/784 series of retractable sensor housings , which are designed ...
(Date:11/24/2015)... 24, 2015 HemoShear Therapeutics, LLC, a ... for metabolic disorders, announced today the appointment of ... of Directors (BOD). Mr. Watkins is the former ... Sciences (HGS), and also served as the chairman ... Powers , Chairman and CEO of HemoShear Therapeutics. ...
Breaking Biology Technology:
(Date:11/19/2015)... -- Although some 350 companies are actively involved in molecular ... according to Kalorama Information. These include Roche Diagnostics, Hologic, Abbott ... of the 6.1 billion-dollar molecular testing market, according to ... Diagnostic s .    ... one company and only a handful of companies can ...
(Date:11/18/2015)... --> --> ... report titled  Gesture Recognition Market - Global Industry Analysis, ... to the report, the global gesture recognition market was valued at ... US$29.1 bn by 2021, at a CAGR of 20.3% ... dominated the global gesture recognition market in ...
(Date:11/17/2015)... 17, 2015 Paris ... --> Paris , qui s,est ... DERMALOG, le leader de l,innovation biométrique, a inventé le ... et empreintes sur la même surface de balayage. Jusqu,ici, ... l,autre pour les empreintes digitales. Désormais, un seul scanner ...
Breaking Biology News(10 mins):